120 related articles for article (PubMed ID: 15660742)
1. 'Disappearing diabetes'--resolution of apparent Type 1 diabetes in a patient with AIDS and cytomegalovirus (CMV) infection.
Evans EM; Nye F; Beeching NJ; Gill GV
Diabet Med; 2005 Feb; 22(2):218-20. PubMed ID: 15660742
[TBL] [Abstract][Full Text] [Related]
2. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences.
Newton CA; Raskin P
Arch Intern Med; 2004 Sep; 164(17):1925-31. PubMed ID: 15451769
[TBL] [Abstract][Full Text] [Related]
3. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
Kobeissy A; Zantout MS; Azar ST
Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
[TBL] [Abstract][Full Text] [Related]
4. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
[TBL] [Abstract][Full Text] [Related]
5. Euglycemic diabetic ketoacidosis in pregnancy.
Tarif N; Al Badr W
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):590-3. PubMed ID: 17951948
[TBL] [Abstract][Full Text] [Related]
6. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
7. Diabetic ketoacidosis complicated by axillary vein thrombosis.
Gill GV; MacNamara G; English P
Diabetes Res Clin Pract; 2006 Jul; 73(1):104-6. PubMed ID: 16414142
[TBL] [Abstract][Full Text] [Related]
8. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.
Noyes KJ; Crofton P; Bath LE; Holmes A; Stark L; Oxley CD; Kelnar CJ
Pediatr Diabetes; 2007 Jun; 8(3):150-6. PubMed ID: 17550425
[TBL] [Abstract][Full Text] [Related]
9. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
[TBL] [Abstract][Full Text] [Related]
10. Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).
Nakamura S; Yoshinari M; Wakisaka M; Kodera H; Doi Y; Yoshizumi H; Asano T; Iwase M; Mihara F; Fujishima M
Diabetes Metab; 2000 Nov; 26(5):407-10. PubMed ID: 11119021
[TBL] [Abstract][Full Text] [Related]
11. Diabetic ketoacidosis and cerebral oedema in Sweden--a 2-year paediatric population study.
Hanas R; Lindgren F; Lindblad B
Diabet Med; 2007 Oct; 24(10):1080-5. PubMed ID: 17672863
[TBL] [Abstract][Full Text] [Related]
12. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus.
Takaike H; Uchigata Y; Iwasaki N; Iwamoto Y
Diabetes Res Clin Pract; 2004 Apr; 64(1):27-32. PubMed ID: 15036824
[TBL] [Abstract][Full Text] [Related]
13. Metabolic control with insulin pump therapy: the Waikato experience.
Reda E; Von Reitzenstein A; Dunn P
N Z Med J; 2007 Jan; 120(1248):U2401. PubMed ID: 17277817
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
Moses RG; Bartley P; Lunt H; O'Brien RC; Donnelly T; Gall MA; Vesterager A; Wollmer P; Roberts A
Diabet Med; 2009 Mar; 26(3):260-7. PubMed ID: 19317821
[TBL] [Abstract][Full Text] [Related]
16. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
[TBL] [Abstract][Full Text] [Related]
17. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study.
Puttha R; Cooke D; Subbarayan A; Odeka E; Ariyawansa I; Bone M; Doughty I; Patel L; Amin R;
Pediatr Diabetes; 2010 Feb; 11(1):12-7. PubMed ID: 19602154
[TBL] [Abstract][Full Text] [Related]
18. Diabetic ketoacidosis in toddler with a diaper rash.
Williams MD; Sallee D; Robinson M
Am J Emerg Med; 2008 Sep; 26(7):834.e1-2. PubMed ID: 18774050
[TBL] [Abstract][Full Text] [Related]
19. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
20. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
